-
-
-
-
-
-
-
Precision BioSciences (DTIL) Tops Q4 EPS by 105c
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Misses Q2 EPS by 213c
-
-
-
-
-
-
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Precision BioSciences to Report Second Quarter Results on August 1, 2024
-
-
-
-
-
-
-
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
-
1,218,292 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

